GGrantIndex
Sort

166,118 grants matching stem cells

Targeting cell state transitions driving resistance to KRAS inhibitors in lung cancer

$735,635
Kwok Kin Wong · New York University School Of Medicine · R01 · FY2024 · CA

T cells in the aging brain

$735,570
Anne Brunet · Stanford University · R01 · FY2022 · AG

Functional mapping of noncoding regulatory variants in human neuronal subtypes

$735,497
Nan Yang · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · MH

Investigating the anti-inflammatory mechanisms of calorie restriction in the aged lacrimal gland

$735,480
Helen P. Makarenkova · Scripps Research Institute, The · R01 · FY2024 · EY

Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential

$735,467
Peter W Laird · Van Andel Research Institute · R01 · FY2019 · CA

Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS

$735,451
Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targets

$735,451
Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Project 3: Integrative and Functional Genomics of Aggressive Prostate Cancer in African American Men

$735,449
John David Carpten · University Of Southern California · U19 · FY2021 · CA

Integrated heart-liver-vascular systems for drug testing in human health and dise

$735,429
Gordana Vunjak-Novakovic · Columbia Univ New York Morningside · UH2 · FY2013 · EB

PROJECT 1: Identification of host and bacterial pathways that control tuberculosis pathogenesis in humans

$735,403
Jeffery S Cox · University Of California, San Francisco · U19 · FY2023 · AI

Murine models of vascular remodeling

$735,394
Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells

$735,392
Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2008 · HD

Mechanisms of Telomere-Mediated Lung Disease

$735,366
Jonathan K. Alder · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL

Northwest Genome Engineering Consortium (Component 1 of 11)

$735,362
Andrew M Scharenberg · Seattle Children'S Hospital · UL1 · FY2009 · DE

Natural History of ABCA4-Related Retinopathies

$735,348
Brian Brooks · National Eye Institute · ZIA · FY2021 · EY

Alpha Synuclein, cellular dysfunction and Parkinson disease

$735,321
Mark Cookson · National Institute On Aging · ZIA · FY2023 · AG

Cilia in Heart Development and Disease

$735,308
Martina Brueckner · Yale University · R35 · FY2024 · HL

Developmental Exposures to Arsenic: Pneumonia, Immunity, and Microbiomes (DEAPIM)

$735,292
Muhammad F Parvez · Columbia University Health Sciences · R01 · FY2023 · ES

Genetic and Stem Cell Model of Cardiac Metabolic Disease

$735,262
Joseph C Wu · Stanford University · R01 · FY2022 · HL

Rational antibody therapy for IPF

$735,251
Andrew R Mendelsohn · Panorama Research, Inc. · R44 · FY2017 · HL

Development of safe and efficient gene therapy strategies for hemoglobinopathies

$735,238
Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2010 · HL

The Role of Wnt Genes in Vertebrate Development and Cancer

$735,207
Terence Yamaguchi · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

The IL-23/IL-17 Axis in Inflammatory Arthritis

$735,191
Iannis Elias Adamopoulos · Beth Israel Deaconess Medical Center · R01 · FY2024 · AR

Origin and Function of Intra-epithelial Mast Cells in Asthma

$735,182
Teal S Hallstrand · University Of Washington · R01 · FY2023 · HL

HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs

$735,163
Steven D Rees · Defined Bioscience, Inc. · R44 · FY2022 · GM